Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205595708> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W3205595708 endingPage "4166" @default.
- W3205595708 startingPage "4157" @default.
- W3205595708 abstract "Combination therapy with anti-programmed death-ligand 1 monoclonal antibody atezolizumab plus anti-vascular endothelial growth factor agent bevacizumab (Atezo/Bev) was approved in 2020 as a first-line treatment for unresectable hepatocellular carcinoma (HCC). Atezo/Bev therapy is relatively well tolerated; however, factors that can predict its response have not yet been reported. Thus, we aimed to investigate whether the pretreatment neutrophil-to-lymphocyte ratio (NLR) could predict the therapeutic response in patients with HCC treated with Atezo/Bev therapy.We analyzed the course of 40 patients with HCC who received Atezo/Bev therapy at our hospital and attempted to identify pretreatment factors that could predict response by comparing those who achieved disease control with those who did not.The pretreatment NLR value in patients who achieved disease control was significantly lower than that in patients with disease progression (2.47 vs. 4.48, p = 0.013). Using the optimal NLR cut-off value for predicting response (3.21) determined by receiver operating characteristic curve analysis, patients with NLR ≤ 3.21 had significantly better progression-free survival than those with NLR > 3.21 (p < 0.0001), although there were no significant differences in liver function or tumor-related background factors between the two groups.The pretreatment NLR value may be a useful predictor of response to Atezo/Bev therapy for HCC." @default.
- W3205595708 created "2021-10-25" @default.
- W3205595708 creator A5001467370 @default.
- W3205595708 creator A5008788188 @default.
- W3205595708 creator A5043965300 @default.
- W3205595708 creator A5053697171 @default.
- W3205595708 creator A5076551859 @default.
- W3205595708 creator A5080874384 @default.
- W3205595708 date "2021-10-14" @default.
- W3205595708 modified "2023-10-18" @default.
- W3205595708 title "Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma" @default.
- W3205595708 cites W1964181833 @default.
- W3205595708 cites W2005041705 @default.
- W3205595708 cites W2071520516 @default.
- W3205595708 cites W2109930846 @default.
- W3205595708 cites W2136011577 @default.
- W3205595708 cites W2581283430 @default.
- W3205595708 cites W2767987989 @default.
- W3205595708 cites W2782319564 @default.
- W3205595708 cites W2883706035 @default.
- W3205595708 cites W2889646458 @default.
- W3205595708 cites W2894822321 @default.
- W3205595708 cites W3013486203 @default.
- W3205595708 cites W3025022288 @default.
- W3205595708 cites W3082999141 @default.
- W3205595708 cites W3123846806 @default.
- W3205595708 cites W3144426753 @default.
- W3205595708 cites W3170378498 @default.
- W3205595708 cites W3188662570 @default.
- W3205595708 doi "https://doi.org/10.3390/curroncol28050352" @default.
- W3205595708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8534657" @default.
- W3205595708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34677270" @default.
- W3205595708 hasPublicationYear "2021" @default.
- W3205595708 type Work @default.
- W3205595708 sameAs 3205595708 @default.
- W3205595708 citedByCount "25" @default.
- W3205595708 countsByYear W32055957082022 @default.
- W3205595708 countsByYear W32055957082023 @default.
- W3205595708 crossrefType "journal-article" @default.
- W3205595708 hasAuthorship W3205595708A5001467370 @default.
- W3205595708 hasAuthorship W3205595708A5008788188 @default.
- W3205595708 hasAuthorship W3205595708A5043965300 @default.
- W3205595708 hasAuthorship W3205595708A5053697171 @default.
- W3205595708 hasAuthorship W3205595708A5076551859 @default.
- W3205595708 hasAuthorship W3205595708A5080874384 @default.
- W3205595708 hasBestOaLocation W32055957081 @default.
- W3205595708 hasConcept C121608353 @default.
- W3205595708 hasConcept C126322002 @default.
- W3205595708 hasConcept C143998085 @default.
- W3205595708 hasConcept C2775949291 @default.
- W3205595708 hasConcept C2776694085 @default.
- W3205595708 hasConcept C2777701055 @default.
- W3205595708 hasConcept C2777761686 @default.
- W3205595708 hasConcept C2777802072 @default.
- W3205595708 hasConcept C2778019345 @default.
- W3205595708 hasConcept C2778963024 @default.
- W3205595708 hasConcept C2780030458 @default.
- W3205595708 hasConcept C58471807 @default.
- W3205595708 hasConcept C71924100 @default.
- W3205595708 hasConcept C90924648 @default.
- W3205595708 hasConceptScore W3205595708C121608353 @default.
- W3205595708 hasConceptScore W3205595708C126322002 @default.
- W3205595708 hasConceptScore W3205595708C143998085 @default.
- W3205595708 hasConceptScore W3205595708C2775949291 @default.
- W3205595708 hasConceptScore W3205595708C2776694085 @default.
- W3205595708 hasConceptScore W3205595708C2777701055 @default.
- W3205595708 hasConceptScore W3205595708C2777761686 @default.
- W3205595708 hasConceptScore W3205595708C2777802072 @default.
- W3205595708 hasConceptScore W3205595708C2778019345 @default.
- W3205595708 hasConceptScore W3205595708C2778963024 @default.
- W3205595708 hasConceptScore W3205595708C2780030458 @default.
- W3205595708 hasConceptScore W3205595708C58471807 @default.
- W3205595708 hasConceptScore W3205595708C71924100 @default.
- W3205595708 hasConceptScore W3205595708C90924648 @default.
- W3205595708 hasFunder F4320320912 @default.
- W3205595708 hasIssue "5" @default.
- W3205595708 hasLocation W32055957081 @default.
- W3205595708 hasLocation W32055957082 @default.
- W3205595708 hasLocation W32055957083 @default.
- W3205595708 hasLocation W32055957084 @default.
- W3205595708 hasLocation W32055957085 @default.
- W3205595708 hasOpenAccess W3205595708 @default.
- W3205595708 hasPrimaryLocation W32055957081 @default.
- W3205595708 hasRelatedWork W2541318045 @default.
- W3205595708 hasRelatedWork W2560684296 @default.
- W3205595708 hasRelatedWork W2898246178 @default.
- W3205595708 hasRelatedWork W2905398573 @default.
- W3205595708 hasRelatedWork W3204015154 @default.
- W3205595708 hasRelatedWork W3216431241 @default.
- W3205595708 hasRelatedWork W4247066646 @default.
- W3205595708 hasRelatedWork W4313045766 @default.
- W3205595708 hasRelatedWork W4317566941 @default.
- W3205595708 hasRelatedWork W4362586345 @default.
- W3205595708 hasVolume "28" @default.
- W3205595708 isParatext "false" @default.
- W3205595708 isRetracted "false" @default.
- W3205595708 magId "3205595708" @default.
- W3205595708 workType "article" @default.